Nektar Therapeutics completes $373.8 million stock offering Apr 23, 2026 04:15PM
Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares Apr 23, 2026 04:15PM
Nektar prices upsized $325 million public offering at $92 per share Apr 21, 2026 09:30PM
Nektar Therapeutics Announces Pricing of Upsized $325 Million Public Offering Apr 21, 2026 09:30PM
Citi Adds Nektar Therapeutics (NKTR) to 30-Day Upside Catalyst Watch List Apr 7, 2026 08:36AM


Apr 28, 2022 04:01PM I-Mab Announces Appointments of Richard Yeh as Chief Operating Officer and John Hayslip as Chief Medical Officer
Jan 15, 2020 09:17AM Pre-Open Movers 01/15: (FLNT) (CLVS) (MNTA) Higher; (NKTR) (TGT) (FSLR) Lower (more...)
Jun 24, 2015 09:30AM Pre-Open Stock Movers 06/24: (MEET) (BOX) (LEN) Higher; (ADHD) (FTNT) (SPLS) Lower (more...)
Mar 18, 2015 12:58PM Unusual 11 Mid-Day Movers 3/18: (VTSS) (NVGN) (RTRX) Higher; (WG) (SQM) (WBAI) Lower
Mar 18, 2015 09:25AM Pre-Open Stock Movers 03/18: (VTSS) (RXDX) (ORCL) Higher; (NKTR) (ADBE) (FDX) Lower (more...)
Nov 12, 2012 10:31AM Notable Analyst Rating Changes 11/12: (SQNM) (DIS) (KLAC) Upgraded; (GRMN) (JCP) (SD) Downgraded
Jun 9, 2010 11:01AM Notable Analyst Rating Changes 06/09: EQIX, POT, BTU, VALE Upgraded; EVVV, RST, FFIV, WTNY Downgraded
Apr 9, 2008 09:27AM Pre-Open Movers 4/9: Nektar (NKTR), MannKind (MNKD) Sink on Inhaled Insulin Worries; EP MedSystems (EPMD) Up on Buyout